Clinical trial

Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

NCT00006116

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record cisplatin Normalized identity: cisplatinView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record gemcitabine hydrochloride Normalized identity: gemcitabine hydrochlorideView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date1999-04-01

PhasePHASE2

Conditions

Lung Cancerverified · MONDO: lung cancer

Interventions

cisplatinDRUG · verified · RxNorm: cisplatin

gemcitabine hydrochlorideDRUG · verified · RxNorm: gemcitabine hydrochloride

Sponsors & collaborators

GERCOR - Multidisciplinary Oncology Cooperative Grouplead sponsor

Mapped research locations

ParisFrance3 ReimsFrance3

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00006116 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.